| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/21/2006 | CA2599663A1 Composition based on an avermectin and azelaic acid in particular for treating rosacea |
| 09/21/2006 | CA2599330A1 Hair and/or scalp care compositions incorporating terpenoid compounds |
| 09/20/2006 | EP1702983A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof |
| 09/20/2006 | EP1702979A2 Improved keratinocyte culture and uses thereof |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1702614A1 Use of idebenone for the preparation of a topically-applied depigmentation composition and corresponding composition |
| 09/20/2006 | EP1702597A2 Drug delivery of phase changing formulation |
| 09/20/2006 | EP1701933A1 Novel compounds |
| 09/20/2006 | EP1554253A4 Imidazolium cxcr3 inhibitors |
| 09/20/2006 | EP1368364B1 C2, 8-disubstituted adenosine derivatives and their different uses |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1292621B1 Compositions for treating autoimmune disease |
| 09/20/2006 | EP1272530B1 Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 09/20/2006 | EP1003577B1 Blood product delivery system |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | CN1835950A Imidazopyridine derivatives |
| 09/20/2006 | CN1835940A Chromen-4-one derivatives |
| 09/20/2006 | CN1835748A Use of cyclopamine in the treatment of psoriasis and other skin disorders |
| 09/20/2006 | CN1834253A Prepn and application of epiderm or hair follicle stem cell from souce of human early embryo |
| 09/20/2006 | CN1833722A Health products for face care and body care |
| 09/20/2006 | CN1833719A Hair growing gel for pelada and lipsotrichia and its prepn. |
| 09/20/2006 | CN1833716A Chinese medicinal preparation for treating acne |
| 09/20/2006 | CN1833715A Skin care gel for skin titillation and prepn. thereof |
| 09/20/2006 | CN1833697A Expelling toxin opsonic water, opsonic pills and prepn. method thereof |
| 09/20/2006 | CN1833696A Face beauty foods for removing chloasma and acne |
| 09/20/2006 | CN1833685A Chinese medicinal compsns. for treating burn and scald, its prepn. and usage |
| 09/20/2006 | CN1833674A Wart gel and prepn. method |
| 09/20/2006 | CN1833673A Externally rubbing 'Bailing' gel for treating leucoderma and its prepn. method |
| 09/20/2006 | CN1833650A Jixuedai dispersion tablet having function of promoting wound reunion, and its prepn. method |
| 09/20/2006 | CN1833649A Jixuedai gel with action of promoting wound reunion, and prepn. thereof |
| 09/20/2006 | CN1833648A Jixuedai drip pill with action of promoting wound reunion, and its prepn. method |
| 09/20/2006 | CN1275977C O-aryl glucoside SGL T2 inhibitors |
| 09/20/2006 | CN1275954C Hydroxamic acid derivatives |
| 09/20/2006 | CN1275938C Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 09/20/2006 | CN1275624C Application of glossy ganoderma spore powder for pharmaceutical preparation |
| 09/20/2006 | CN1275623C Liquor for treating leucoderma and alphos and preparation method thereof |
| 09/20/2006 | CN1275617C Externally applied agent for relieving inflammation and antibiosis |
| 09/20/2006 | CN1275616C Compsn. of medication for treating burns and scalds |
| 09/20/2006 | CN1275611C External remedy for treating Hang Kong foot |
| 09/20/2006 | CN1275606C Medical usage of simonder wood oil |
| 09/20/2006 | CN1275601C Composition and method of tissue superoxygenation |
| 09/20/2006 | CN1275598C Medicine for promoting wound healing |
| 09/20/2006 | CN1275596C Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/19/2006 | US7109342 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 09/19/2006 | US7109333 5-(4-{3-chloro-4-(3-fluorobenzyloxy)-anilino}-6-quinazolinyl)-furan-2-carbaldehyde; selective inhibition of the protein tyrosine kinase activity, minimising side effects |
| 09/19/2006 | US7109246 Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug |
| 09/19/2006 | US7109224 Acyl guanidine compounds and use thereof |
| 09/19/2006 | US7109219 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 09/19/2006 | US7109218 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7109199 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 09/19/2006 | US7109194 3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use |
| 09/19/2006 | US7109191 for inhibiting bone resorption, restenosis, atherosclerosis, inflammatory arthritis, diabetic retinopathy, macular degeneration, angiogenesis, cancer |
| 09/19/2006 | US7109176 For therapy of inflammatory diseases and conditions in humans and animals |
| 09/19/2006 | US7109164 Administering compounds such as 3-[[3,5-dibromo-[4-hydroxy-3-(1-methylethyl)phenoxy]-phenyl]amino]-3-oxopropanoic acid for therapy of obesity, hypercolesterolemia atherosclerosis, depression, osteoporosis, hypothyroidism, goiter, glaucoma, cardiac arrhythmia, congestive heart failure, or a skin disorder |
| 09/19/2006 | US7109160 Peptides containing the motif IGD and their use as cell migration modulators |
| 09/19/2006 | US7108987 Factors participating in degranulation of mast cells, DNAs encoding the same, method of screening of these factors and the inhibitors |
| 09/19/2006 | US7108868 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
| 09/19/2006 | CA2154601C Formulations containing coumarins and the use thereof in the pharmaceutical and cosmetic fields |
| 09/19/2006 | CA2149459C Acylated aminoalkanimidazoles and -triazoles |
| 09/14/2006 | WO2006096360A1 Topical gels compositions |
| 09/14/2006 | WO2006095906A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 09/14/2006 | WO2006095836A1 Antipruritic agent for pruritus caused by multiple sclerosis |
| 09/14/2006 | WO2006095764A1 Agent for suppressing uv sensitivity in skin and functional beverage and food |
| 09/14/2006 | US20060205763 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205762 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205723 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/14/2006 | US20060205715 6-(8-Pentylamino-5,6,7,8-tetrahydro-naphthalen-2-yloxy)-nicotinamide; increase metabolic energy consumption, and reduction of weight; obesity, antidiabetic agent, eating disorders; antidepressant, anxiolytic agent |
| 09/14/2006 | US20060205712 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 09/14/2006 | US20060205708 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/14/2006 | US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 09/14/2006 | US20060205673 2-Amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives |
| 09/14/2006 | US20060205659 Peptide radical having 5-25 amino acids with its N-terminus capped with a monoester of fumaric acid; used to treat autoimmune diseases, mitochondrial diseases, and NF-kappaB mediated diseases and in transplantation medicine |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205646 Methods for increasing cell and tissue viability |
| 09/14/2006 | US20060204593 Superoxide anion decomposing agent |
| 09/14/2006 | US20060204591 Treatment of mucosal membranes |
| 09/14/2006 | US20060204552 comprising pantothenic acid, nicotinamide, histidine, inositol and choline, its use in the treatment of a canine skin disease |
| 09/14/2006 | US20060204489 Protein C derivatives |
| 09/14/2006 | US20060204471 Compositions and regime/regimen for treating the adverse signs of cutaneous skin aging |
| 09/14/2006 | US20060204459 Use of tyrosine inhibitors for whitening human skin and treating melanocyted dysfunction associated diseases |
| 09/14/2006 | US20060204446 Topical immunotherapy and compositions for use therein |
| 09/14/2006 | DE19922287B4 Verwendung von Flavonoidestern in Kosmetika Use of Flavonoidestern in cosmetics |
| 09/14/2006 | DE102006006115A1 New quinoxaline derivatives useful e.g. in cosmetic and pharmaceutical preparation as photo stable UV-filter with reduced skin penetration potential to protect human skin or hair against sun radiation |
| 09/14/2006 | DE102005011459A1 Verwendung kosmetischer Zubereitungen mit einem Gehalt an nicht molekular gebundenem freien Sauerstoff Use of cosmetic preparations containing not molecularly bonded free oxygen |
| 09/14/2006 | DE102005008002A1 Cream having 5-lipoxygenase inhibitory activity, useful for the treatment of psoriatic symptoms such as inflammation of the skin, comprises incense components |
| 09/14/2006 | CA2604071A1 Antipruritic agent for pruritus caused by multiple sclerosis |
| 09/14/2006 | CA2599968A1 Topical gels compositions |
| 09/14/2006 | CA2599879A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 09/13/2006 | EP1700921A2 Regulation of a human asparagine-hydroxylase |
| 09/13/2006 | EP1700617A1 Composition for activating the hair follicules and use thereof |
| 09/13/2006 | EP1700603A2 Immunostimulatory nucleic acids |
| 09/13/2006 | EP1700600A1 Fulvic acid and its use in the treatment of inflammation |
| 09/13/2006 | EP1700599A1 Fulvic acid and its use in the treatment of candida infections |
| 09/13/2006 | EP1699475A2 An extract of the fruit of schisandra chinensis and its pharmaceutical and cosmetic use |
| 09/13/2006 | EP1699423A1 Use of a lyophilisate of dedifferentiated plant cells for skin depigmentation and/or lightening |
| 09/13/2006 | EP1532145B1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 09/13/2006 | EP1442050B1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 09/13/2006 | EP1389206B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |